Whalegun
Home

Alnylam Pharmaceuticals ALNY paid Tiber Creek Group $60K for lobbying in Q4 2023 · Medicare

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q4 2023
Stock
Alnylam Pharmaceuticals ALNY
Client
Alnylam Pharmaceuticals
Reported
24/01/16

Up 0.0% from last quarter

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

Alnylam Pharmaceuticals's other lobbying reports

Alnylam Pharmaceuticals ALNY paid Tiber Creek Group $60K for lobbying in Q4 2023 · Medicare | Whalegun